0.00Open0.01Pre Close0 Volume1.14K Open Interest152.50Strike Price0.00Turnover7428.57%IV17.23%PremiumNov 22, 2024Expiry Date0.00Intrinsic Value100Multiplier-4DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0037Delta0.0012Gamma13009.00Leverage Ratio-121.0308Theta0.0000Rho47.63Eff Leverage0.0000Vega
Target Stock Discussion
1. Innovative Pipeline: TPST is a clinical-stage biotechnology company focused on developing small molecule therapeutics for cancer treatment. Their leading programs, TPST-1495 and TPST-1120, are in Phase 1 trials targeting various tumors.
2. Strategic Partnerships: The company has a collaboration with Roche to advance TPST-1120 in combination with other therapies...
No comment yet